| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.1M | +13.9% |
| R&D Expense | $37.4M | +1.1% |
| SG&A Expense | $11.9M | -12.0% |
| Operating Income | -$8.3M | +43.1% |
| Interest Expense | $491K | +0.0% |
| Pre-tax Income | -$7.7M | +39.6% |
| Income Tax | $361K | -37.8% |
| Net Income | -$8.1M | +39.5% |
| EPS (Basic) | -$0.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.1M | -22.1% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $25.0M | -49.4% |
| Total Assets | $25.6M | -49.3% |
| Current Liabilities | $6.4M | -76.9% |
| Total Liabilities | $6.5M | -76.6% |
| Stockholders' Equity | $19.1M | -15.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.0M | +12.7% |
| Capital Expenditures | $85K | +70.0% |
| Investing Cash Flow | $13.8M | +390.1% |
| Financing Cash Flow | $164K | +101.8% |
| Free Cash Flow | -$19.1M | +12.5% |
| +39.5% |
| EPS (Diluted) | -$0.23 | +39.5% |